Antibiotic shows promise for treating fragile X syndrome

04/10/2013 | Disability Scoop

Children with fragile X syndrome who received minocycline had modest improvements in anxiety levels and mood-related behaviors compared with a placebo group, researchers report in the Journal of Developmental and Behavioral Pediatrics. Some patients responded better to the medication than others, and researchers are looking for predictive biomarkers.

View Full Article in:

Disability Scoop

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health